Home » Human Genome: Journal Reviews Lupus Drug Endpoints Positively
Human Genome: Journal Reviews Lupus Drug Endpoints Positively
Human Genome announces a publication by the journal Arthritis Care & Research of an article describing the development and use of a novel evidence-based systemic lupus erythematosus (SLE) Responder Index selected as the primary endpoint of two pivotal Phase III clinical trials of BENLYSTA in serologically active patients with SLE.
MSN
MSN
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May